when do compounding pharmacies have to stop making semaglutide Has compound medication availability changed? Novo Nordisk asks FDA to

Clinicians sometimes pair a GLP-1 receptor agonist (such as semaglutide) with phentermine for selected patients

Watch out for copycats The popularity of GLP-1s has shifted from diabetes treatment to lifestyle management, creating shortages and ethical questions about access

However, your health care provider might consider alternatives such as Wegovy, Mounjaro, or Saxenda, all of which are GLP-1 medications but not all are FDA-approved for weight loss specifically.

Understanding Steady State Many patients starting GLP-1 receptor agonist therapy wonder whether these medications accumulate in the body over time

To learn more about your potential claim, call LBL using our toll-free number (800) 698-4054 or complete our online intake form today